On the other hand, calcitriol, the most active vitamin D metabolite, exerts pro-differentiating and antiproliferative effects in breast cancer [14], and has shown an anti-EMT effect in epithelial cells through inhibiting the PI3K/Akt/β-catenin pathway [15]. Here, AKT1 is linked to breast cancer.